# FDA Inspection 1250745 - OXYGEN DEVELOPMENT, L.L.C. - September 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/951e75e0-9474-4220-8341-ba8cd5ae30a1
Source feed: FDA_Inspections

> FDA inspection 1250745 of OXYGEN DEVELOPMENT, L.L.C., September 11, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250745
- Company Name: OXYGEN DEVELOPMENT, L.L.C.
- Inspection Date: 2025-09-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1295654 - 2026-05-19
- FDA Inspection 1042460 - 2018-01-19
- [FDA Inspection 1039561 - 2018-01-17](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/9deefb7a-9015-45ac-b4cf-eb9d000bd06d)
- [FDA Inspection 857278 - 2013-11-22](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/83b1d754-fed3-4709-8a26-932a779f6a8b)
- [FDA Inspection 824681 - 2013-03-29](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/71aada83-67bb-4e02-ae37-670289f578ea)

## Related Officers

- [Alan A. Rivera](https://www.keypedia.com/people/alan-a-rivera/4bec02c3-c62e-4b3a-a6ab-02c3386549bf)

Company: https://www.keypedia.com/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9